Stock Analiz

Oric Pharmaceuticals, Inc. (ORIC) stock forecast and price target

Price $7.86 · data as of November 13, 2026

12-month price target

Average target$21.71
Upside / downside+176.3%
Analysts14
ConsensusStrong buy
Low $14.00Average $21.71High $27.00

Gold marker: average target · white marker: today’s price ($7.86)

Analyst ratings

Strong buy 2Buy 12Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.49−1.5%$0
Next fiscal year
ends December 31, 2027
$-1.69−13.0%$0
Quarter after
ends December 31, 2026
$-0.40−31.7%$0

Consensus of the analysts covering Oric Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Oric Pharmaceuticals stock price target?

The average 12-month target from 14 analysts is $21.71, 176.3% above the current price of $7.86 Targets range from $14.00 to $27.00.

Is Oric Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 12 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Oric Pharmaceuticals expected to earn?

Analysts expect EPS of $-1.49 for the fiscal year ending December 31, 2026 and $-1.69 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.